21:11 EDT Cathie Wood’s ARK Investment buys 55K shares of Beam Therapeutics (BEAM) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics: Advancements in Gene Editing and Promising Clinical Milestones Justify Buy Rating
- 3 Best Stocks to Buy Now, 6/26/2025, According to Top Analysts
- JPMorgan’s Bullish Outlook on Beam Therapeutics: Promising Genetic Base-Editing Platform and Strategic Growth Prospects
- Beam Therapeutics Receives Buy Rating on Promising Sickle Cell Therapy Data and Market Potential
- Bullish Outlook on Beam Therapeutics Driven by Promising Clinical Data and Market Opportunities